CD8A and neoplasm: Eikawa et al. reported that metformin increased the number of CD8(+) tumor-infiltrating lymphocytes (TILs) and protected them from apoptosis and dysfunction, and increased the production of IL-2, TNFα, and IFN-γ in mouse model13.